Minimally Invasive Neurosurgery (02172): NUMEN Helia Spring Coil receives FDA approval for market listing in the United States.

Wisdom Finance APP News, MicroPort NeuroNexus (02172) announced that the NUMEN Helia spring coil embolization system developed independently by its subsidiary MicroPort NeuroNexus Medical Technology (Shanghai) Co., Ltd. recently obtained official market approval from the U.S. Food and Drug Administration (FDA).